474 related articles for article (PubMed ID: 23402640)
1. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer.
Zhao W; You L; Hou X; Chen S; Ren X; Chen G; Zhao Y
Ann Surg Oncol; 2017 Aug; 24(8):2189-2198. PubMed ID: 27913945
[TBL] [Abstract][Full Text] [Related]
3. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis.
Chen L; Wu YH; Lee CH; Chen HA; Loh EW; Tam KW
World J Surg; 2018 Sep; 42(9):2846-2857. PubMed ID: 29488066
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis.
Zhao WJ; Luo H; Zhou YM; Dai WY; Zhu JQ
Eur J Surg Oncol; 2017 Nov; 43(11):1989-2000. PubMed ID: 28807633
[TBL] [Abstract][Full Text] [Related]
7. A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Lang BH; Wong CK
Ann Surg Oncol; 2014 Feb; 21(2):416-25. PubMed ID: 23982258
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Central Neck Dissection Might Not Be Necessary in Papillary Thyroid Carcinoma: Analysis of 11,569 Cases from a Single Institution.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
J Am Coll Surg; 2016 May; 222(5):853-64. PubMed ID: 27113516
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.
Yang J; Han Y; Min Y; Chen C; Chen J; Xiang K; Liao J; Feng Y; Hu D; Yin G
Front Endocrinol (Lausanne); 2023; 14():1176512. PubMed ID: 37576962
[TBL] [Abstract][Full Text] [Related]
10. Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma.
Zhu W; Zhong M; Ai Z
Jpn J Clin Oncol; 2013 Sep; 43(9):883-8. PubMed ID: 23858039
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward.
Dismukes J; Fazendin J; Obiarinze R; Márquez GCH; Ramonell KM; Buczek E; Lindeman B; Chen H
J Surg Res; 2021 Aug; 264():230-235. PubMed ID: 33838407
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors and pattern of locoregional recurrence after prophylactic central neck dissection in papillary thyroid carcinoma.
Lang BH; Chan DT; Wong KP; Wong KK; Wan KY
Ann Surg Oncol; 2014 Dec; 21(13):4181-7. PubMed ID: 24990632
[TBL] [Abstract][Full Text] [Related]
13. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and safety of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma patients: A meta-analysis.
Wang Y; Xiao Y; Pan Y; Yang S; Li K; Zhao W; Hu X
Front Endocrinol (Lausanne); 2022; 13():1094012. PubMed ID: 36733809
[TBL] [Abstract][Full Text] [Related]
15. Long-term Results of Observation vs Prophylactic Selective Level VI Neck Dissection for Papillary Thyroid Carcinoma at a Cancer Center.
Ywata de Carvalho A; Chulam TC; Kowalski LP
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):599-606. PubMed ID: 25997016
[TBL] [Abstract][Full Text] [Related]
16. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
Barczyński M; Konturek A; Stopa M; Nowak W
Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
18. A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Wong CK; Lang BH
Ann Surg Oncol; 2014 Mar; 21(3):767-77. PubMed ID: 24276639
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
20. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data.
Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
